SciTransfer
Organization

FUNDACION AGENCIA ARAGONESA PARA LA INVESTIGACION Y EL DESARROLLO

Aragón's research talent foundation hosting scientists across health, biotech, and agriculture in EU-funded projects.

Regional research support foundationhealthESNo active H2020 projectsThin data (2/5)
H2020 projects
4
As coordinator
1
Total EC funding
€170K
Unique partners
47
What they do

Their core work

ARAID is the Aragón regional foundation for research and development, acting as a talent-hosting agency that recruits and supports researchers across disciplines in Zaragoza, Spain. Rather than running its own labs, it provides institutional backing and career frameworks that allow researchers to participate in EU-funded projects through partner universities and institutes. Its H2020 footprint spans livestock sustainability, tuberculosis drug research, and bio-based materials for composite recycling — reflecting the breadth of researchers it hosts rather than a single technical focus.

Core expertise

What they specialise in

Sustainable livestock systems (sheep and goats)secondary
1 project

Contributed as third party to iSAGE (2016-2020), a major project on sustainable sheep and goat production covering breeding, climate adaptation, and consumer trends.

Tuberculosis drug development (beta-lactams)primary
1 project

Coordinated BLMs 4 TB (2018-2020), an MSCA Individual Fellowship project exploring beta-lactam antibiotics for tuberculosis treatment — their only coordinated and directly funded project.

Enzyme engineering for composite recyclingemerging
1 project

Participated as third party in BIZENTE (2020-2024), applying ligninolytic enzymes and directed evolution to break down thermoset composite plastics.

Evolution & trajectory

How they've shifted over time

Early focus
Livestock sustainability and science outreach
Recent focus
Biotech and advanced materials

In the early H2020 period (2014-2016), ARAID's involvement centered on science outreach and agricultural sustainability — promoting research careers while contributing to livestock system studies. By the later period (2018-2024), the focus shifted markedly toward molecular biology and materials science, with tuberculosis drug research and enzyme-based degradation of thermoset composites. This evolution reflects ARAID's nature as a researcher-hosting foundation: its portfolio follows the individual scientists it recruits rather than a single institutional research agenda.

ARAID is moving toward applied biotechnology — enzyme engineering and drug development — suggesting future collaborations will likely involve molecular-level innovation with industrial or health applications.

Collaboration profile

How they like to work

Role: third_party_expertReach: European9 countries collaborated

ARAID operates predominantly as a third-party contributor (2 of 4 projects), providing hosted researchers to existing consortia rather than leading them. They coordinated one MSCA fellowship (BLMs 4 TB), which is an individual researcher grant rather than a large consortium effort. With 47 unique partners across 9 countries from just 4 projects, they plug into large, well-connected consortia — making them a flexible specialist contributor rather than a consortium-building hub.

Despite only 4 projects, ARAID has touched 47 unique partners across 9 countries, entirely through joining large consortia. Their network is broad but indirect — built through the projects of the researchers they host rather than through institutional partnerships.

Why partner with them

What sets them apart

ARAID's distinctiveness lies in its role as a regional talent agency for research — it does not operate labs but provides the institutional framework for individual researchers to join EU projects. This makes it unusually flexible: its expertise is as broad as the scientists it hosts, spanning from livestock breeding to enzyme engineering to TB pharmacology. For consortium builders, ARAID offers a gateway to Aragón's research talent pool with minimal institutional overhead.

Notable projects

Highlights from their portfolio

  • BLMs 4 TB
    ARAID's only coordinated project and sole direct EC funding (EUR 170,122) — an MSCA fellowship on beta-lactam antibiotics for tuberculosis, signaling strong individual researcher capacity in infectious disease.
  • BIZENTE
    Their most recent and forward-looking project (2020-2024), applying enzyme-based approaches to recycle thermoset composite plastics — connecting biotechnology to circular economy challenges.
Cross-sector capabilities
Food & agriculture (livestock sustainability, breeding programs)Environment & circular economy (enzyme-based plastic recycling)Society & public engagement (science communication, researcher visibility)Advanced materials (thermoset composites, bio-based resin degradation)
Analysis note: With only 4 projects (2 as third party with no direct funding), the profile is thin. ARAID's true scope is likely much broader than what H2020 data shows, since as a researcher-hosting agency its contributions may be captured under partner institutions. The diverse and seemingly unrelated project topics confirm it functions as an umbrella body rather than a focused research lab. Direct EC funding data exists for only 1 project.